The Gut Microbiota as Target for Innovative Drug Development: Perspectives and a Case Study of Inflammatory Bowel Diseases

doi 10.5772/27905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

The Gut Microbiota and Inflammatory Bowel Diseases

Translational Research
BiochemistryPublic HealthEnvironmentalMedicinePhysiologyOccupational Health
2017English

Gut Microbiota: A Promising Target Against Cardiometabolic Diseases

Expert Review of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2020English

The Gut Microbiota in Immune-Mediated Inflammatory Diseases

Frontiers in Microbiology
Microbiology
2016English

The Gut Microbiota in Mouse Models of Inflammatory Bowel Disease

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2014English

Effect of Resistant Starch on Inflammatory Bowel Diseases and Microbiota

Journal of Traditional Medical Complementary Therapies
2020English

Role of Commensal Gut Bacteria in Inflammatory Bowel Diseases

Gut Microbes
Infectious DiseasesMicrobiologyGastroenterology
2012English

Calprotectin as a Diagnostic Tool for Inflammatory Bowel Diseases

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2016English

Catestatin as a Target for Treatment of Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2018English

Exercise in Patients With Inflammatory Bowel Diseases: Current Perspectives

Clinical and Experimental Gastroenterology
Gastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy